Live Breaking News & Updates on Risk Committee Mr Michael Spooner

NEW YORK, Sept. 26, 2023 (GLOBE NEWSWIRE) Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that independent Director Jane Bell AM has been appointed Chair of the Mesoblast Board Audit and Risk Committee. Ms Bell joined the Board in August 2022, and is a banking and finance lawyer with 30 years of corporate finance expertise focussing on international investment transactions in the United States, Canada, Austral ....

South Australia , United States , City Of , United Kingdom , Steve Dabkowski , Silviu Itescu , Paul Hughes , Corporate Communications Investors , Risk Committee Mr Michael Spooner , Commercialization Committee , Australian Securities Exchange , Melbourne Health , Risk Committee , Monash Health , Mesoblast Limited Nasdaq , Zealand College Of Obstetricians , Melbourne Genomics Health Alliance , Bachelor Of Laws University Melbourne , Bachelor Of Economics Monash University , Audit Committee , King College London , Hudson Institute Of Medical Research , Mesoblast The Company , Director Jane Bell , Mesoblast Board Audit , Chief Executive Silviu Itescu ,